The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

Completed

Conditions studied: Myocardial Infarction

In brief

The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcomes. In patients with Myocardial Infarction (MI) discharged from the hospital, beta-blocker dose will be predictive of survival. Exploratory analyses: Gender and racial effects-gender and race are, similarly, hypothesized to be predictive of post-MI survival. The existence of interactions between gender and beta-blocker effect as well as race and beta-blocker effect will also be evaluated.

Key facts

Study ID
NCT00430612
Run by
Northwestern University
People needed
7057
Starts
2009-05-01
Expected to finish
2015-10-01
Last updated by the study team
2023-04-24

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.